A multi-center, double-blind, placebo-controlled therapeutic trial to determine whether natural huperzine A improves cognitive function.

Trial Profile

A multi-center, double-blind, placebo-controlled therapeutic trial to determine whether natural huperzine A improves cognitive function.

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Apr 2011

At a glance

  • Drugs Huperzine A (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Apr 2011 Primary endpoint 'Alzheimer's Disease Assessment Scale-cognitive subscale' has not been met, as published in Neurology.
    • 19 Apr 2011 Results published in Neurology.
    • 02 Feb 2008 Top-line results from the double-blind part of the study reported in a Neuro-Hitech media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top